Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Institute of Pharmaceutical Industry (SIPI), also known as the Shandong Academy of Pharmaceutical Sciences, is a leading comprehensive pharmaceutical research and development institution based in Jinan, China. Established in 1982, the institute specializes in the research of chemical synthetic drugs, biotechnology, traditional Chinese medicine, and advanced pharmaceutical preparations. SIPI is globally recognized for its pioneering work in hyaluronic acid research, which laid the foundation for the Freda brand and the broader Chinese hyaluronic acid industry. The institute provides a wide range of services including drug discovery, process optimization, and clinical trial management, while maintaining a robust portfolio of commercialized products and innovative candidates in oncology, cardiovascular, and ophthalmology therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Institute of Pharmaceutical Industry.